Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giorgi

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Oncology Reports|June 21, 2006
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patientsP Correale, D Cerretani, C Remondo, et al.
European Journal of Endocrinology|June 10, 2010
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasiaG Occhi, G Trivellin, F Ceccato, et al.
British Journal of Cancer|July 17, 2003
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acidP Correale, S Messinese, S Marsili, et al.
British Journal of Cancer|January 22, 2004
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancerR Petrioli, M Sabatino, A I Fiaschi, et al.
Journal of Medicinal Chemistry|May 7, 1999
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptorsA Cappelli, M Anzini, S Vomero, et al.
British Journal of Cancer|May 20, 2004
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinomaP Correale, S Messinese, M Caraglia, et al.
Journal of Chemotherapy (Florence, Italy)|January 5, 2002
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthaseP Correale, M Sabatino, M G Cusi, et al.
Journal of Medicinal Chemistry|July 19, 1996
Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockersG Campiani, I Fiorini, M P De Filippis, et al.
The Journal of Biological Chemistry|September 27, 2001
The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464: a novel generation of nonnucleoside inhibitorsG Maga, A Ramunno, V Nacci, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Oncology Reports|June 21, 2006
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patientsP Correale, D Cerretani, C Remondo, et al.
European Journal of Endocrinology|June 10, 2010
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasiaG Occhi, G Trivellin, F Ceccato, et al.
British Journal of Cancer|July 17, 2003
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acidP Correale, S Messinese, S Marsili, et al.
British Journal of Cancer|January 22, 2004
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancerR Petrioli, M Sabatino, A I Fiaschi, et al.
Journal of Medicinal Chemistry|May 7, 1999
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptorsA Cappelli, M Anzini, S Vomero, et al.
British Journal of Cancer|May 20, 2004
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinomaP Correale, S Messinese, M Caraglia, et al.
Journal of Chemotherapy (Florence, Italy)|January 5, 2002
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthaseP Correale, M Sabatino, M G Cusi, et al.
Journal of Medicinal Chemistry|July 19, 1996
Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockersG Campiani, I Fiorini, M P De Filippis, et al.
The Journal of Biological Chemistry|September 27, 2001
The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464: a novel generation of nonnucleoside inhibitorsG Maga, A Ramunno, V Nacci, et al.
Pageof 13